The Difference | World Medical Innovation Forum - Gene and Cell Therapy
Boston
May 2–4, 2022

The Difference

Translation from concept to clinical. Curation by Harvard Medical faculty. A focus on the path to implementation. No other conference shines a light on the transition from promise to patient.

Discover

A first look at the early-stage work of Harvard-based principal investigators.

Get an up-close look at research that will create the next wave of GCT-driven healthcare innovation. The work of principal investigators across the Mass General Brigham network presents an insightful tableau of emerging inquiry to inform investment priorities.

Develop

The industry leaders who select, invest in, and cultivate tomorrow’s breakthroughs converge for three days of exclusive meetings.

Boston is the global epicenter of biotech innovation. Mass General Brigham represents many of the most respected pillars of the academic research community. Each year, Mass General Brigham invites leaders from around the world to join in a dialogue that will shape the future of medicine.

Translate

Opportunities to assess the speed at which new GCT technologies will become clinical realities.

Moving GCT innovation into clinical practice depends on everything from robust research practices to prudent piloting to smart partnering. The Forum program provides insight into the pace of implementation of GCT-based products in clinical settings.

Disseminate

Attendees learn how 100s of clinicians set the agenda for widespread implementation of new GCT-driven technology.

Implementing GCT breakthroughs requires educating practitioners on the front lines of patient care. Mass General Brigham helps set industry priorities for clinical care, education and training.

The Institutions

Harvard Medical School

Founded in 1782, HMS is one of the oldest medical schools in the United States and is ranked first among research-oriented medical schools in the 2020 rankings of U.S. News and World Report.

Brigham and Women’s Hospital

BWH is an internationally-known referral center for the most complex cases in nearly all areas of medicine. U.S. News and World Report has consistently ranked it a top hospital and among the best in specialty areas.

Massachusetts General Hospital

MGH is the #1 hospital on the East Coast, having been named #2 in America by U.S. News and World Report. It is the only hospital to be recognized across all 16 specialties assessed by U.S. News.

Mass. Eye and Ear

Massachusetts Eye and Ear is an international center for treatment and home to the world’s largest vision and hearing research centers. It is also a teaching hospital of Harvard Medical School.

McLean Hospital

Founded in 1811, McLean is a leader in psychiatric care, research, and education and is the largest psychiatric teaching hospital of Harvard Medical School.

Newton-Wellesley Hospital

NWH has been named as one of Solucient’s 100 Top Hospitals for five years. The Boston Globe has named NWH to their list of “Top Places to Work 2018”.

Spaulding Rehabilitation Network

The network is anchored by Spaulding Rehabilitation Hospital, which is ranked as the #3 rehab hospital in the country by U.S. News & World Report for 2019-20 and is the only rehab hospital in New England ranked the last 25 years.

The Programs

First Look

Harvard Medical School investigators present their work with rapid fire presentations of their high potential new technologies which will impact the future of medicine in gene and cell therapy.

Disruptive Dozen

Harvard faculty from BWH and MGH select technologies that will have the greatest impact on the chosen field of the event in the next 18 months.

Posters

Nearly 50 gene and cell therapy technologies profiled by Harvard Medical School inventors and clinicians who will bring technologies to patients.

the Future of Medicine and AI

May 11–13, 2020 | Boston, MA